Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent (Q36098775)

12 August 2017

Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent (English)

1 reference

12 August 2017

4

Thomas R Fritsche

1 reference

12 August 2017

3

Ronald N Jones

1 reference

12 August 2017

5

Cindy C Knapp

1 reference

12 August 2017

Robert P Rennie

1

1 reference

12 August 2017

Laura Koeth

series ordinal

2

1 reference

12 August 2017

Scott B Killian

series ordinal

6

1 reference

12 August 2017

Beth P Goldstein

series ordinal

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Journal of Clinical Microbiology

12 August 2017

1 reference

12 August 2017

45

1 reference

12 August 2017

10

1 reference

12 August 2017

3151-3154

1 reference

Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using gram-positive organisms

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2045359

Antistaphylococcal activity of dalbavancin, an experimental glycopeptide

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2045359

Effect of zinc concentration in Mueller-Hinton agar on susceptibility of Pseudomonas aeruginosa to imipenem

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2045359

Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2045359

Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infections

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2045359

Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2045359

Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004).

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2045359

Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2045359

Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2045359

Initial quality control evaluations for susceptibility testing of Dalbavancin (BI397), an investigational glycopeptide with potent gram-positive activity

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2045359

23 September 2018

Identifiers

DOI

10.1128/JCM.02411-06

1 reference

12 August 2017

1 reference

12 August 2017

1 reference